These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18836730)

  • 1. Effects of botulinum toxin injection on anal achalasia after pull-through operations for Hirschsprung's disease: a 1-year follow-up study.
    Jiang da P; Xu CQ; Wu B; Li ZZ; Zhang YB; Han FY
    Int J Colorectal Dis; 2009 May; 24(5):597-8. PubMed ID: 18836730
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of anal achalasia after transanal endorectal pull-through for Hirschsprung's disease with topical botulinum toxin.
    Jiang da P; Li ZZ; Zhang YB; Jiang ZT
    J Trop Pediatr; 2008 Jun; 54(3):211. PubMed ID: 18156643
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease.
    Patrus B; Nasr A; Langer JC; Gerstle JT
    J Pediatr Surg; 2011 Jan; 46(1):184-7. PubMed ID: 21238663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.
    Minkes RK; Langer JC
    J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Hirschsprung disease by botulinum toxin A through anorectal injection].
    Du YH; Peng Q; Liu M; Zhi Y; Chen H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):144-6. PubMed ID: 16155827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.
    Langer JC; Birnbaum E
    J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histology and function of the internal anal sphincter after injection of botulinum toxin.
    Langer JC; Birnbaum EE; Schmidt RE
    J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of anal fissure using botulinum toxin: perianal thrombosis as a complication].
    Jost WH; Schanne S; Schimrigk K; Mlitz H
    Dtsch Med Wochenschr; 1995 May; 120(18):665. PubMed ID: 7750437
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease.
    Wester T; Granström AL
    Pediatr Surg Int; 2015 Mar; 31(3):255-9. PubMed ID: 25616563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia.
    Church JT; Gadepalli SK; Talishinsky T; Teitelbaum DH; Jarboe MD
    J Pediatr Surg; 2017 Jan; 52(1):74-78. PubMed ID: 27836361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study.
    Bassotti G; D'Onofrio V; Battaglia E; Fiorella S; Dughera L; Iaquinto G; Mazzocchi A; Morelli A; Annese V
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1615-9. PubMed ID: 16696811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated pull-through surgery for complicated Hirschsprung's disease--principles derived from clinical experience.
    Schweizer P; Berger S; Schweizer M; Holschneider AM; Beck O
    J Pediatr Surg; 2007 Mar; 42(3):536-43. PubMed ID: 17336195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rehbein's procedure in 73 cases of Hirschsprung's disease.
    Thepcharoennirund S
    J Med Assoc Thai; 2004 Oct; 87(10):1188-92. PubMed ID: 15560696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up study on postoperative function after a transanal Soave 1-stage endorectal pull-through procedure for Hirschsprung's disease.
    Huang Y; Zheng S; Xiao X
    J Pediatr Surg; 2008 Sep; 43(9):1691-5. PubMed ID: 18779008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of anismus in intractable constipation with botulinum A toxin.
    Hallan RI; Williams NS; Melling J; Waldron DJ; Womack NR; Morrison JF
    Lancet; 1988 Sep; 2(8613):714-7. PubMed ID: 2901570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transanal endorectal pull-through in children with Hirschsprung's disease--technical refinements and comparison of results with the Duhamel procedure.
    Tannuri AC; Tannuri U; Romão RL
    J Pediatr Surg; 2009 Apr; 44(4):767-72. PubMed ID: 19361638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of botulinum toxin injection in treatment of achalasia].
    Hoeft SF; Porschen R
    Z Gastroenterol; 2000 Jan; 38(1):133-5. PubMed ID: 10689751
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.
    Langer JC; Rollins MD; Levitt M; Gosain A; Torre L; Kapur RP; Cowles RA; Horton J; Rothstein DH; Goldstein AM;
    Pediatr Surg Int; 2017 May; 33(5):523-526. PubMed ID: 28180937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of isosorbide dinitrate in patients with persistent constipation after pull-through surgery for Hirschsprung's disease.
    Messina M; Amato G; Meucci D; Molinaro F; Nardi N
    Eur J Pediatr Surg; 2007 Feb; 17(1):62-5. PubMed ID: 17407025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.